Home » Topics » Regulatory » Patents

Patents
RSS

Iovance Biotherapeutics discloses new PD-L1 binding proteins

Feb. 8, 2018

Bayer divulges novel TASK-1/3 blockers

Feb. 8, 2018

Ensoltek describes new peptides acting as RAGE receptor ligands

Feb. 8, 2018

INSERM and collaborators patent stromal cell-derived factor 1 inhibitors

Feb. 8, 2018

Astellas divulges new melanocortin MC4 receptor agonists

Feb. 7, 2018

Novel 5-HT7 receptor agonists identified at the Institute of Pharmacology

Feb. 7, 2018

Bioway describes novel PI3Kdelta/PI3Kgamma inhibitors

Feb. 7, 2018

Lifesci Pharmaceuticals discloses new plasma kallikrein inhibitors

Feb. 7, 2018

Novel PAR-4 antagonists discovered at Bristol-Myers Squibb

Feb. 7, 2018

Incyte discovers new PD-1/PD-L1 interaction inhibitors

Feb. 6, 2018

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...